Abstract
Background
Objectives
Methods
Results
Conclusions
Key Words
Abbreviations:
ICD (implantable cardioverter-defibrillator), HFrEF (heart failure and reduced ejection fraction), LVEF (left ventricular ejection fraction), 2DE (2-dimensional echocardiography), MUGA (multi-gated acquisition radionuclide ventriculography), SCD-HeFT (Sudden Cardiac Death in Heart Failure trial), SCD (sudden cardiac death), NHLBI (National Heart Lung and Blood Institute), CMR (cardiac magnetic resonance imaging)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart RhythmReferences
- Mode of Death in Advanced Heart Failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial.J Am Coll Cardiol. 2005; 46: 2329-2334
- Disrupting the approach to sudden cardiac death: From vulnerable ejection fraction to vulnerable patient.Circulation. 2018; 137: 7-9
Priori SG, Blomströ M-Lundqvist C. ESC GUIDELINES 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.Circulation. 2018; 138: e272-e391
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. 2005.
- Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure Analysis From the Sudden Cardiac Death in Heart Failure Trial.Circulation. 2009; 120: 2170-2176
- Powerlessness of a Number: Why Left Ventricular Ejection Fraction Matters Less for Sudden Cardiac Death Risk Assessment.Circ Cardiovasc Imaging. 2016; 9: 212-217
- Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario.Can J Cardiol. 2010; 26: e118
- Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.Int J Cardiovasc Imaging. 2019; 35: 2085-2093
- Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography.Neth Heart J. 2014; 22: 449-455
Aly MFA, Kleijn SA, Menken-Negroiu · R F, Robbers · L F, Beek · A M, Kamp · O. Three-dimensional speckle tracking echocardiography and cardiac magnetic resonance for left ventricular chamber quantification and identification of myocardial transmural scar. Netherlands Hear J. 2016;
Keil L, Chevalier C, Kirchhof P, et al. Molecular Sciences CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy. 2021; Int J Mol Sci. 2021;22.
Weng Z, Yao J, Chan RH, et al. Prognostic Value of LGE-CMR in HCM A Meta-Analysis. 2016; JACC Cardiovasc Imaging. 2016;9:1392-1402.
Article info
Publication history
Publication stage
In Press Journal Pre-ProofFootnotes
Funding: Dr. Ahmed was in part supported by grants from the Department of Veterans Affairs (I01HX002422).
Disclosures: Dr. Fonarow reports consulting with Abbott, Amgen, Astra Zeneca, Bayer, Cytokinetics, Edwards, Janssen, Medtronic, Merck, and Novartis. None of the other authors report any conflicts of interest related to this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs.
